Advertisement

Topics

Companies Related to "A Study To Look At Safety And Blood Concentrations After Multiple Doses Of PF-03382792 In Healthy Elderly Individuals" [Most Relevant Company Matches] RSS

11:04 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "A Study To Look At Safety And Blood Concentrations After Multiple Doses Of PF-03382792 In Healthy Elderly Individuals" found in our extensive corporate database of over 50,000 company records.

Showing "Study Look Safety Blood Concentrations After Multiple Doses" Companies 1–25 of 3,600+

Relevant

GlycoMark, Inc.

GlycoMark is an FDA-cleared blood test that reveals repeated episodes of postprandial hyperglycemia/glycemic variability by tracking postprandial glucose levels as they related to blood levels of the molecule 1,5-anhydroglucitol (1,5-AG). Multiple published studies indicate that 1,5-AG detects hyperglycemia not detected by the hemoglobin A1C test. A recent study conducted as part of the internat...


Multiple Myeloma Research Foundation

The Multiple Myeloma Research Foundation (MMRF) was established in 1998 as a 501(c)3 non-profit organization by twin sisters Karen Andrews and Kathy Giusti, soon after Kathy's diagnosis with multiple myeloma. The mission of the MMRF is to relentlessly pursue innovative means that accelerate the development of next-generation multiple myeloma treatments to ...

Ameritox

The single-group, multi-dose study examined the ability of the Rx Guardian(SM) algorithm to differentiate among low, medium and high daily doses of OxyContin®. Oxycodone levels were detected in the urine of 36 healthy volunteers using a liquid chromatography-mass spectrometry (LC-MS-MS) assay. Participants were randomized to receive 80mg, 160mg or 240mg of daily OxyContin® to steady state cond...


MedPro Safety Products, Inc.

Headquartered in Lexington, Kentucky, MedPro Safety Products, Inc. is a leading developer of safer medication delivery and blood collection systems. The Company licenses, develops and manufactures transformational technologies to be marketed through its global medical device partners. MedPro’s products address multiple product categories within the me...

Multiple Myeloma Research Foundation (MMRF)

Multiple myeloma is an incurable blood cancer. The five-year relative survival rate for multiple myeloma is approximately 38 percent, one of the lowest of all cancers. In 2010, more than 20,000 adults in the United States will be diagnosed with multiple myeloma and nearly 11,000 people are predicted to die from the disease.

The Multiple Myeloma Research Consortium (MMRC)

Multiple myeloma is an incurable blood cancer. The five-year relative survival rate for multiple myeloma is approximately 38 percent, one of the lowest of all cancers. In 2011, more than 20,000 adults in the United States will be diagnosed with multiple myeloma and nearly 11,000 people are predicted to die from the disease.

Northfield Laboratories

Northfield Laboratories Inc. is a leader in developing an oxygen-carrying red blood cell substitute for the treatment of life-threatening blood loss, when an oxygen-carrying fluid is required and red blood cells are not available. Northfield’s product, PolyHeme®, is a human hemoglobin-based temporary oxygen-carrying red blood cell substitute. PolyHeme® simultaneously restores lost blood volum...

Cellerant Therapeutics Inc.

Cellerant Therapeutics is a clinical stage biotechnology company focused on the regulation of the hematopoietic (blood-forming) system. The Company is developing human stem cell and antibody therapies for oncology applications and blood-related disorders. Cellerant’s lead product, CLT-008 is currently in Phase 1 clinical trials evaluating safety in pa...

The Multiple Myeloma Research Foundation

Multiple myeloma is an incurable blood cancer. The five-year relative survival rate for multiple myeloma is approximately 34 percent, one of the lowest of all cancers. In 2009, approximately 20,000 adults in the United States were diagnosed with multiple myeloma and approximately 11,000 people died from the disease.

China Cord Blood Corporation

China Cord Blood Corporation is the first and the largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood bank operator with multiple licenses. Under the current PRC government regulations, only one licensed cord blood bank operator is permitted to operate in each licensed region and only six licenses have been issued as of today. China Cord Bl...

Hanson Technologies, Inc.

Hanson Technologies is an innovator in food and water safety solutions. Hanson's technology solutions are based on a series of patented technologies. The firm's technology solutions have multiple applications including food safety testing, blood diagnostics and agricultural testing. To learn more about Hanson Technologies, please call 717-245-9890, or visit www.hansontechnologies.com.

Foxhollow Technologies

An estimated 12 million people in the U.S. alone have peripheral arterial disease (PAD). At least 40% of them also suffer from coronary artery disease (CAD). FoxHollow recently launched the SilverHawk® Plaque Excision System, a device that removes the plaque that commonly blocks arteries and interrupts blood flow. Unlike stenting and other methods of opening the artery, the SilverHawk removes the...

Cardinal Health Nuclear Pharmacy Services

The Total Solution™ is what you get from America's #1 radiopharmacy services provider. It starts with our Unit Dose Service, which guarantees the highest quality standards and delivery of the right dose, at the right place, at the right time. Then it adds a list of value-added services, including safety solutions, department management, operational excellence, professional consultation and IT so...

HemoStat Laboratories

HemoStat is involved in the field of microbiology, or the study of microorganisms and their activities. Microorganisms can be simple plants, such as algae, more complex forms like bacteria or fungi, or parasites, like viruses and rickettsiae. Whatever their form, they play an important and often dominant role in all aspects of life.HemoStat Labs is divided into two main functional areas: blood bag...

The Focused Ultrasound Surgery Foundation

MRgFUS is a disruptive technology that is poised to revolutionize the treatment of a wide variety of medical disorders by serving as the ultimate in minimally invasive surgery; an alternative to radiation therapy; the means for precisely delivering drugs in high concentrations to the point where they are needed; and, dissolving blood clots and restoring circulation.

Fenwal Inc.

Fenwal Inc. is a global medical technology company focused on improving blood collection, separation, safety and availability for patient care. Fenwal became an independent company in 2007, but its roots go back to 1949 with the founding of Fenwal Laboratories. Fenwal developed the first flexible, disposable container for blood collection, eliminating complications associated with glass containe...

Cytheris SA

Cytheris is a privately held clinical-stage biopharmaceutical company focused on research and development of therapies for immune modulation.  These drugs aim at reconstituting and enhancing the immune system of patients suffering from cancer, chronic viral or bacterial infections such as HIV, HCV, and HBV or lympho-depleting treatments such as chemotherapy, radiotherapy, bone marrow transp...

The Blood Alliance

The Blood Alliance (TBA) provides blood and blood products to more than 20 hospitals and medical facilities in 10 counties serving Northeast Florida, and portions of Georgia and South Carolina. It provides the best possible blood banking system to the regions it serves. TBA opened in 1942 and is a non-profit community blood center licensed by the FDA and accredited by the AABB. For more informatio...

BioTechNews Denmark

TopoTarget and CuraGen Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for MesotheliomaTopoTarget A/S and CuraGen Corporation announced today the initiation of patient dosing in a Phase II clinical trial evaluating the activity of PXD101, a small molecule histone deacetylase (HDAC) inhibitor, for the treatment of mesothelioma. This trial is being sponsored by the National ...

Sanquin

Sanquin was established in 1998 through a merger between the Dutch blood banks and the Central Laboratory of the Netherlands Red Cross Blood Transfusion Service (CLB). The Foundation is responsible for blood supply on a not-for-profit basis and advances transfusion medicine as such that it fulfils the highest demands for quality, safety and efficiency. Sanquin delivers products and services, condu...

Fenwal, Inc.

Fenwal, Inc. is a global medical technology company focused on improving blood collection, filtration, separation, storage and transfusion to ensure the availability, safety and effectiveness of blood components. Fenwal is unique in the depth of its experience and commitment to transfusion medicine. The company offers the broadest range of products for the automated and manual collection of blood ...

Consortium for Plasma Science LLC

The Consortium for Plasma Science, LLC, was formed in January 1997 to support the development of a universal approach to eradicate pathogens in whole blood plasma. The Consortium is cofunded by Alpha Therapeutic Corporation, a subsidiary of Mitsubishi Pharma Corporation; Aventis Behring; Baxter Healthcare Corporation; and Bayer Corporation.The Member companies have agreed on a focused strategy to ...

Finnish Red Cross Blood Service

The Finnish Red Cross Blood Service is the nationwide blood service provider in Finland. The Blood Service collects blood and processes it into such preparations and medicinal products as hospitals require for treating patients. The Blood Service is a financially and operationally independent section of the Finnish Red Cross. Each year 300 000 bags of blood are donated in Finland, with up to 60 00...

Specialized Health Products International

We are a developer,manufacturer and marketer of proprietary disposable medical devices for clinician and patient safety. Our innovative safety devices are designed to maximize the effieiency and quality of healthcare,while minimizing the risk of accidental needlesticks. We have developed multiple safety needle products based upon a broad intellectual property portfolio that applies to virtually al...

Haemonetics

For more than 30 years, Haemonetics has been a global leader in blood processing technology. The Company has two families of products:Donor Products - These products are marketed to the blood donation industry and include products that automate the blood donation process, automate the processing of blood, support pathogen inactivation and bacterial detection of blood, and test blood hematocrit.Pat...


More From BioPortfolio on "A Study To Look At Safety And Blood Concentrations After Multiple Doses Of PF-03382792 In Healthy Elderly Individuals"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks